Target intelligence / Profile preview

RNA, 7SL, cytoplasmic 320, pseudogene (RN7SL320P)

Target
RN7SL320P
Molecular classification
Pseudogene, Non-coding RNA pseudogene, Processed pseudogene
01

Overview

RN7SL320P (RNA, 7SL, cytoplasmic 320, pseudogene) is a human *processed pseudogene*, one of many genomic loci that are derived from the 7SL RNA gene but rendered non-functional due to mutations, truncations, or a lack of regulatory elements required for proper expression[5][1][3][7]. 7SL RNA is the RNA component of the signal recognition particle (SRP), which is essential in protein targeting to the endoplasmic reticulum, but the vast majority of 7SL-derived pseudogenes—including RN7SL320P—do not produce functional RNA or protein[1][8][7]. Some pseudogenes, under certain circumstances, may be transcribed and can play roles in gene regulation (such as acting as decoys or sponges for microRNAs), but for RN7SL320P specifically, there is no evidence of functional activity or disease association in the literature[5][7][4]. **Summary of key points:** - RN7SL320P is a processed pseudogene, not an active gene or therapeutic target[5][7]. - It has no known function in human biology and is not associated with any diseases as of current knowledge[5][7][4]. - It is not a drug target, nor does it have recognized interacting drugs, biomarker status, or safety concerns. - While some non-coding RNA pseudogenes perform regulatory roles, such functions have not been described for RN7SL320P[6][9].

Other names
RN7SL320PRNA, 7SL, cytoplasmic 320, pseudogene
02

Biological functions

Other (pseudogenes may play regulatory roles as non-coding RNAs, including potential *competitive endogenous RNA* activity or miRNA sponge functions, but most are non-functional)[4][6][9]
03

Disease associations

Other (although some pseudogenes can be implicated in cancer or regulation of gene expression, RN7SL320P specifically has no demonstrated disease role)[6][4]

Beyond the preview

Go deeper on RNA, 7SL, cytoplasmic 320, pseudogene (RN7SL320P).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on RNA, 7SL, cytoplasmic 320, pseudogene (RN7SL320P).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call